Who we are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a... Backed by Accel.
About the role
The Associate Director, Bioanalytical Sciences & Biomarkers will lead bioanalytical and biomarker assay strategy, development, validation, and non-clinical and clinical sample analysis oversight for Arbor’s in vivo gene editing programs, from IND-enabling studies through clinical trials. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Develop, qualify, and validate assays supporting IND-enabling, GLP toxicology, and clinical studies for in vivo gene editing programs
- Define assay development, qualification, validation, and sample analysis plans appropriate for non-GLP, GLP, and GCLP studies, applying ICH M10 and fit-for-purpose, context-of-use principles
- Lead vendor/CRO selection, assay transfer, method validation planning, troubleshooting, and oversight of external laboratory execution
- Oversee non-clinical and clinical bioanalytical sample analysis, including sample flow, testing cadence, assay run quality, data review, issue resolution, and timely delivery of results
- Interpret biomarker, assay, and translational data and translate findings into clear recommendations for program teams and leadership
- Author validation reports, bioanalytical study reports, and the assay sections of IND/CTA submissions
More about this role
Why this role matters.
The Associate Director, Bioanalytical Sciences & Biomarkers will lead bioanalytical and biomarker assay strategy, development, validation, and non-clinical and clinical sample analysis oversight for Arbor’s in vivo gene editing programs, from IND-enabling studies through clinical trials.
Reporting to the Senior Director, Translational Research, this individual will serve as the assay lead on cross-functional program teams, partnering closely with In Vivo Pharmacology, Clinical Development, Regulatory, Quality, and external laboratory partners. The role is responsible for ensuring assay strategies are scientifically rigorous, operationally executable, and aligned with program and regulatory objectives.
The core of this role is regulated assay work. You have led method development and validation for assays used in both GLP toxicology studies and clinical trials.
This role leads an in-house assay team and is on-site in Cambridge 4–5 days per week.
What you'll own.
- Develop, qualify, and validate assays supporting IND-enabling, GLP toxicology, and clinical studies for in vivo gene editing programs.
- Own the assays behind key endpoints, including editing...
Browse similar: Startup jobs